奧特佳(002239.SZ):最高人民法院准許劉斌撤回再審請求
格隆匯 12 月 18日丨奧特佳(002239.SZ)公佈,公司12月18日收到中華人民共和國最高人民法院發來的民事裁定書[(2020)最高法民審5125號]。該裁定準許再審申請人劉斌撤回就公司股東王進飛冒用公司名義簽署債務擔保協議相關案件所提出的再審申請。
中華人民共和國最高人民法院民事裁定書[(2020)最高法民審5125號]的主要內容如下:准許劉斌撤回再審申請。
最高人民法院准許劉斌撤回再審請求,表明公司相關司法風險已經完全消除。此事對公司的生產經營及財務狀況沒有影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.